Cargando…

Access to unpublished protocols and statistical analysis plans of randomised trials

BACKGROUND: Access to protocols and statistical analysis plans (SAPs) increases the transparency of randomised trial by allowing readers to identify and interpret unplanned changes to study methods, however they are often not made publicly available. We sought to determine how often study investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, David, McDonald, Cassandra, Cro, Suzie, Jairath, Vipul, Kahan, Brennan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387046/
https://www.ncbi.nlm.nih.gov/pubmed/35978391
http://dx.doi.org/10.1186/s13063-022-06641-x
_version_ 1784769942211526656
author Campbell, David
McDonald, Cassandra
Cro, Suzie
Jairath, Vipul
Kahan, Brennan C.
author_facet Campbell, David
McDonald, Cassandra
Cro, Suzie
Jairath, Vipul
Kahan, Brennan C.
author_sort Campbell, David
collection PubMed
description BACKGROUND: Access to protocols and statistical analysis plans (SAPs) increases the transparency of randomised trial by allowing readers to identify and interpret unplanned changes to study methods, however they are often not made publicly available. We sought to determine how often study investigators would share unavailable documents upon request. METHODS: We used trials from two previously identified cohorts (cohort 1: 101 trials published in high impact factor journals between January and April of 2018; cohort 2: 100 trials published in June 2018 in journals indexed in PubMed) to determine whether study investigators would share unavailable protocols/SAPs upon request. We emailed corresponding authors of trials with no publicly available protocol or SAP up to four times. RESULTS: Overall, 96 of 201 trials (48%) across the two cohorts had no publicly available protocol or SAP (11/101 high-impact cohort, 85/100 PubMed cohort). In total, 8/96 authors (8%) shared some trial documentation (protocol only [n = 5]; protocol and SAP [n = 1]; excerpt from protocol [n = 1]; research ethics application form [n = 1]). We received protocols for 6/96 trials (6%), and a SAP for 1/96 trial (1%). Seventy-three authors (76%) did not respond, 7 authors responded (7%) but declined to share a protocol or SAP, and eight email addresses were invalid (8%). A total of 329 emails were sent (an average of 41 emails for every trial which sent documentation). After emailing authors, the total number of trials with an available protocol increased by only 3%, from 52% in to 55%. CONCLUSIONS: Most study investigators did not share their unpublished protocols or SAPs upon direct request. Alternative strategies are needed to increase transparency of randomised trials and ensure access to protocols and SAPs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-06641-x.
format Online
Article
Text
id pubmed-9387046
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93870462022-08-19 Access to unpublished protocols and statistical analysis plans of randomised trials Campbell, David McDonald, Cassandra Cro, Suzie Jairath, Vipul Kahan, Brennan C. Trials Research BACKGROUND: Access to protocols and statistical analysis plans (SAPs) increases the transparency of randomised trial by allowing readers to identify and interpret unplanned changes to study methods, however they are often not made publicly available. We sought to determine how often study investigators would share unavailable documents upon request. METHODS: We used trials from two previously identified cohorts (cohort 1: 101 trials published in high impact factor journals between January and April of 2018; cohort 2: 100 trials published in June 2018 in journals indexed in PubMed) to determine whether study investigators would share unavailable protocols/SAPs upon request. We emailed corresponding authors of trials with no publicly available protocol or SAP up to four times. RESULTS: Overall, 96 of 201 trials (48%) across the two cohorts had no publicly available protocol or SAP (11/101 high-impact cohort, 85/100 PubMed cohort). In total, 8/96 authors (8%) shared some trial documentation (protocol only [n = 5]; protocol and SAP [n = 1]; excerpt from protocol [n = 1]; research ethics application form [n = 1]). We received protocols for 6/96 trials (6%), and a SAP for 1/96 trial (1%). Seventy-three authors (76%) did not respond, 7 authors responded (7%) but declined to share a protocol or SAP, and eight email addresses were invalid (8%). A total of 329 emails were sent (an average of 41 emails for every trial which sent documentation). After emailing authors, the total number of trials with an available protocol increased by only 3%, from 52% in to 55%. CONCLUSIONS: Most study investigators did not share their unpublished protocols or SAPs upon direct request. Alternative strategies are needed to increase transparency of randomised trials and ensure access to protocols and SAPs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-06641-x. BioMed Central 2022-08-17 /pmc/articles/PMC9387046/ /pubmed/35978391 http://dx.doi.org/10.1186/s13063-022-06641-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Campbell, David
McDonald, Cassandra
Cro, Suzie
Jairath, Vipul
Kahan, Brennan C.
Access to unpublished protocols and statistical analysis plans of randomised trials
title Access to unpublished protocols and statistical analysis plans of randomised trials
title_full Access to unpublished protocols and statistical analysis plans of randomised trials
title_fullStr Access to unpublished protocols and statistical analysis plans of randomised trials
title_full_unstemmed Access to unpublished protocols and statistical analysis plans of randomised trials
title_short Access to unpublished protocols and statistical analysis plans of randomised trials
title_sort access to unpublished protocols and statistical analysis plans of randomised trials
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387046/
https://www.ncbi.nlm.nih.gov/pubmed/35978391
http://dx.doi.org/10.1186/s13063-022-06641-x
work_keys_str_mv AT campbelldavid accesstounpublishedprotocolsandstatisticalanalysisplansofrandomisedtrials
AT mcdonaldcassandra accesstounpublishedprotocolsandstatisticalanalysisplansofrandomisedtrials
AT crosuzie accesstounpublishedprotocolsandstatisticalanalysisplansofrandomisedtrials
AT jairathvipul accesstounpublishedprotocolsandstatisticalanalysisplansofrandomisedtrials
AT kahanbrennanc accesstounpublishedprotocolsandstatisticalanalysisplansofrandomisedtrials